Radiopharmaceutical Market 2018 Global Analysis By Key Players – Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes

Summary

WiseGuyReports.com adds “Radiopharmaceutical Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Radiopharmaceutical Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Radiopharmaceutical Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Radiopharmaceutical market status and forecast, categorizes the global Radiopharmaceutical market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. 
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field. 
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share. 
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

The global Radiopharmaceutical market is valued at 4940 million US$ in 2017 and will reach 9520 million US$ by the end of 2025, growing at a CAGR of 8.6% during 2018-2025.

The major manufacturers covered in this report 
Bracco Imaging 
Bayer 
Mallinckrodt 
Nordion 
Triad Isotopes 
Lantheus 
IBA Group 
GE Healthcare 
China Isotope & Radiation 
Jubilant Pharma 
Eli Lilly 
Advanced Accelerator Applications 
SIEMENS 
Dongcheng 
Navidea

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Actinium-225 
Lutetium-177 
Radium-223 
Holmium-166 
Other 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Oncology 
Cardiology 
Other

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3213650-global-radiopharmaceutical-market-research-report-2018

Major Key Points in Table of Content

Global Radiopharmaceutical Market Research Report 2018 
1 Radiopharmaceutical Market Overview 
1.1 Product Overview and Scope of Radiopharmaceutical 
1.2 Radiopharmaceutical Segment by Type (Product Category) 
1.2.1 Global Radiopharmaceutical Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Radiopharmaceutical Production Market Share by Type (Product Category) in 2017 
1.2.3 Actinium-225 
1.2.4 Lutetium-177 
1.2.5 Radium-223 
1.2.6 Holmium-166 
1.2.7 Other 
1.3 Global Radiopharmaceutical Segment by Application 
1.3.1 Radiopharmaceutical Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Oncology 
1.3.3 Cardiology 
1.3.4 Other 
1.4 Global Radiopharmaceutical Market by Region (2013-2025) 
1.4.1 Global Radiopharmaceutical Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Radiopharmaceutical (2013-2025) 
1.5.1 Global Radiopharmaceutical Revenue Status and Outlook (2013-2025) 
1.5.2 Global Radiopharmaceutical Capacity, Production Status and Outlook (2013-2025)

……

7 Global Radiopharmaceutical Manufacturers Profiles/Analysis 
7.1 Bracco Imaging 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Radiopharmaceutical Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Bracco Imaging Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview 
7.2 Bayer 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Radiopharmaceutical Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Bayer Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 Mallinckrodt 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Radiopharmaceutical Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Mallinckrodt Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Nordion 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Radiopharmaceutical Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Nordion Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Triad Isotopes 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Radiopharmaceutical Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Triad Isotopes Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 
7.5.4 Main Business/Business Overview 
7.6 Lantheus 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 Radiopharmaceutical Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 Lantheus Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.6.4 Main Business/Business Overview 
7.7 IBA Group 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 Radiopharmaceutical Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 IBA Group Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.7.4 Main Business/Business Overview 
7.8 GE Healthcare 
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.8.2 Radiopharmaceutical Product Category, Application and Specification 
7.8.2.1 Product A 
7.8.2.2 Product B 
7.8.3 GE Healthcare Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.8.4 Main Business/Business Overview 
7.9 China Isotope & Radiation 
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.9.2 Radiopharmaceutical Product Category, Application and Specification 
7.9.2.1 Product A 
7.9.2.2 Product B 
7.9.3 China Isotope & Radiation Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.9.4 Main Business/Business Overview 
7.10 Jubilant Pharma 
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.10.2 Radiopharmaceutical Product Category, Application and Specification 
7.10.2.1 Product A 
7.10.2.2 Product B 
7.10.3 Jubilant Pharma Radiopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2013-2020) 
7.10.4 Main Business/Business Overview 
7.11 Eli Lilly 
7.12 Advanced Accelerator Applications 
7.13 SIEMENS 
7.14 Dongcheng 
7.15 Navidea

At any Query @ https://www.wiseguyreports.com/enquiry/3213650-global-radiopharmaceutical-market-research-report-2018

Continued....

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

ADDRESS:
WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India

This release was published on openPR.